Elixir CE marks DESyne novolimus-eluting stent; launch in Q3
This article was originally published in Clinica
Executive Summary
A new drug-eluting stent (DES) will soon hit the European market: Elixir Medical's novolimus-coated DESyne. The Sunnyvale, California firm has CE marked the product for the treatment of coronary artery disease.